References - Why Useless Knowledge Can Be So Useful
References - Why Useless Knowledge Can Be So Useful
Day, Jonathan W., Nickki Ottaway, James T. Patterson, Vasily Gelfanov, David Smiley, Jas Gidda, Hannes Findeisen, et al. “A New Glucagon and GLP-1 Co-Agonist Eliminates Obesity in Rodents.” Nature Chemical Biology 5, no. 10 (October 2009): 749–57. https://doi.org/10.1038/nchembio.209.
Eng, J, P C Andrews, W A Kleinman, L Singh, and J P Raufman. “Purification and Structure of Exendin-3, a New Pancreatic Secretagogue Isolated from Heloderma Horridum Venom.” Journal of Biological Chemistry 265, no. 33 (November 1990): 20259–62. https://doi.org/10.1016/S0021-9258(17)30498-2.
Eng, J., W. A. Kleinman, L. Singh, G. Singh, and J. P. Raufman. “Isolation and Characterization of Exendin-4, an Exendin-3 Analogue, from Heloderma Suspectum Venom. Further Evidence for an Exendin Receptor on Dispersed Acini from Guinea Pig Pancreas.” Journal of Biological Chemistry 267, no. 11 (April 15, 1992): 7402–5. https://doi.org/10.1016/S0021-9258(18)42531-8.
Finan, Brian, Tao Ma, Nickki Ottaway, Timo D. Müller, Kirk M. Habegger, Kristy M. Heppner, Henriette Kirchner, et al. “Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans.” Science Translational Medicine 5, no. 209 (October 30, 2013): 209ra151-209ra151. https://doi.org/10.1126/scitranslmed.3007218.
Finan, Brian, Bin Yang, Nickki Ottaway, David L Smiley, Tao Ma, Christoffer Clemmensen, Joe Chabenne, et al. “A Rationally Designed Monomeric Peptide Triagonist Corrects Obesity and Diabetes in Rodents.” Nature Medicine 21, no. 1 (January 2015): 27–36. https://doi.org/10.1038/nm.3761.
Flexner, Abraham. “The Usefulness of Useless Knowledge.” Harper’s Magazine, November 1939.
Lund, P. Kay. “The Discovery of Glucagon-like Peptide 1.” Regulatory Peptides 128, no. 2 (June 2005): 93–96. https://doi.org/10.1016/j.regpep.2004.09.001.
National Institute on Aging. “Exendin-4: From Lizard to Laboratory...and Beyond,” July 11, 2012. https://www.nia.nih.gov/news/exendin-4-lizard-laboratory-and-beyond.
Ng, Marie, Xiaochen Dai, Rebecca M. Cogen, Michael Abdelmasseh, Arash Abdollahi, Auwal Abdullahi, Richard Gyan Aboagye, et al. “National-Level and State-Level Prevalence of Overweight and Obesity among Children, Adolescents, and Adults in the USA, 1990–2021, and Forecasts up to 2050.” The Lancet 404, no. 10469 (December 7, 2024): 2278–98. https://doi.org/10.1016/S0140-6736(24)01548-4.
“On the Causation of the So-Called ‘Peripheral Reflex Secretion’ of the Pancreas. (Preliminary Communication.),” n.d.
Raufman, J. P., R. T. Jensen, V. E. Sutliff, J. J. Pisano, and J. D. Gardner. “Actions of Gila Monster Venom on Dispersed Acini from Guinea Pig Pancreas.” American Journal of Physiology-Gastrointestinal and Liver Physiology 242, no. 5 (May 1, 1982): G470–74. https://doi.org/10.1152/ajpgi.1982.242.5.G470.
Raufman, Jean-Pierre. “Bioactive Peptides from Lizard Venoms.” Regulatory Peptides 61, no. 1 (January 16, 1996): 1–18. https://doi.org/10.1016/0167-0115(96)00135-8.
Tata, Jamshed R. “One Hundred Years of Hormones.” EMBO Reports 6, no. 6 (June 2005): 490–96. https://doi.org/10.1038/sj.embor.7400444.
Tsend-Ayush, Enkhjargal, Chuan He, Mark A. Myers, Sof Andrikopoulos, Nicole Wong, Patrick M. Sexton, Denise Wootten, Briony E. Forbes, and Frank Grutzner. “Monotreme Glucagon-like Peptide-1 in Venom and Gut: One Gene – Two Very Different Functions.” Scientific Reports 6, no. 1 (November 29, 2016): 37744. https://doi.org/10.1038/srep37744.
Zhao, Xin, Minghe Wang, Zhitong Wen, Zhihong Lu, Lijuan Cui, Chao Fu, Huan Xue, Yunfeng Liu, and Yi Zhang. “GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.” Frontiers in Endocrinology 12 (August 23, 2021). https://doi.org/10.3389/fendo.2021.721135.
Zheng, Zhikai, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, and Junjie Gao. “Glucagon-like Peptide-1 Receptor: Mechanisms and Advances in Therapy.” Signal Transduction and Targeted Therapy 9, no. 1 (September 18, 2024): 1–29. https://doi.org/10.1038/s41392-024-01931-z.